JP2023519361A5 - - Google Patents
Info
- Publication number
- JP2023519361A5 JP2023519361A5 JP2022558345A JP2022558345A JP2023519361A5 JP 2023519361 A5 JP2023519361 A5 JP 2023519361A5 JP 2022558345 A JP2022558345 A JP 2022558345A JP 2022558345 A JP2022558345 A JP 2022558345A JP 2023519361 A5 JP2023519361 A5 JP 2023519361A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridyl
- amino
- triazolo
- pyrimidine
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994970P | 2020-03-26 | 2020-03-26 | |
| US62/994,970 | 2020-03-26 | ||
| PCT/EP2021/057807 WO2021191379A1 (en) | 2020-03-26 | 2021-03-25 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519361A JP2023519361A (ja) | 2023-05-10 |
| JP2023519361A5 true JP2023519361A5 (https=) | 2024-04-01 |
| JP7774573B2 JP7774573B2 (ja) | 2025-11-21 |
Family
ID=75339741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558345A Active JP7774573B2 (ja) | 2020-03-26 | 2021-03-25 | トリアゾロン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12528815B2 (https=) |
| EP (1) | EP4126873A1 (https=) |
| JP (1) | JP7774573B2 (https=) |
| KR (1) | KR20230051118A (https=) |
| CN (1) | CN115867280B (https=) |
| AU (1) | AU2021243725A1 (https=) |
| CA (1) | CA3177056A1 (https=) |
| WO (1) | WO2021191379A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025512384A (ja) | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｒｏｐ－２発現がんを治療するための併用療法 |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7452892B2 (en) * | 2005-06-17 | 2008-11-18 | Bristol-Myers Squibb Company | Triazolopyrimidine cannabinoid receptor 1 antagonists |
| ATE457988T1 (de) | 2006-06-26 | 2010-03-15 | Schering Corp | A2a-adenosin-rezeptor-antagonisten |
| JP2011513417A (ja) * | 2008-03-04 | 2011-04-28 | シェーリング コーポレイション | アデノシンＡ２ａ受容体アンタゴニストとして使用するための１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オンおよびピラゾロ［４，３−ｅ］−１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オン化合物 |
| AU2011306358B2 (en) | 2010-09-24 | 2014-08-14 | Impetis Biosciences Ltd. | Fused tricyclic compounds as adenosine receptor antagonist |
| EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| AU2018233367B2 (en) | 2017-03-16 | 2021-08-12 | Jiangsu Hengrui Medicine Co., Ltd. | Heteroaryl[4,3-c]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof |
-
2021
- 2021-03-25 CA CA3177056A patent/CA3177056A1/en active Pending
- 2021-03-25 EP EP21715862.5A patent/EP4126873A1/en active Pending
- 2021-03-25 KR KR1020227037223A patent/KR20230051118A/ko active Pending
- 2021-03-25 CN CN202180038082.7A patent/CN115867280B/zh active Active
- 2021-03-25 US US17/914,196 patent/US12528815B2/en active Active
- 2021-03-25 JP JP2022558345A patent/JP7774573B2/ja active Active
- 2021-03-25 WO PCT/EP2021/057807 patent/WO2021191379A1/en not_active Ceased
- 2021-03-25 AU AU2021243725A patent/AU2021243725A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI868441B (zh) | 非環氧氮呯化合物及其用途 | |
| JP2015511245A5 (https=) | ||
| ES2377849T3 (es) | Compuestos amino-heterocíclicos | |
| EP3630770B1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| ES2420860T3 (es) | Compuestos amino-heterocíclicos usados como inhibidores de la PDE9 | |
| JP2022500402A5 (https=) | ||
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP2025535367A (ja) | ６－アザ部分を含むオキサゼピン化合物およびその使用 | |
| HRP20240994T1 (hr) | Spoj inhibitora jak i njegova uporaba | |
| JP2016538316A5 (https=) | ||
| JP2014506929A5 (https=) | ||
| RU2008110915A (ru) | Новые диазаспироалканы и их применение для лечения заболеваний, опосредованных ccr8 | |
| JP2016500073A5 (https=) | ||
| JP2024123079A (ja) | トリアゾロ－ピリミジン化合物およびそれらの使用 | |
| EP2920177A1 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP2013522354A5 (https=) | ||
| RU2013120966A (ru) | ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ | |
| RU2017121278A (ru) | Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы | |
| JP2015522002A5 (https=) | ||
| JP2013523884A5 (https=) | ||
| JP2016515098A5 (https=) | ||
| TW201542520A (zh) | 炔基醇及其使用方法 | |
| JP2016537384A5 (https=) | ||
| JP2017518326A5 (https=) | ||
| JP2023519361A5 (https=) |